Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Sep 13, 2021
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Updates to the Non-Discrimination Legal Requirements for NIH Recipients
National Institutes of Health
General Notices
- Notice of Pre-Application Webinar for the "Translational and Basic Science Research in Early Lesions (TBEL)" Program: RFA-CA-21-054 and RFA-CA-21-055
National Cancer Institute
- The NIH Office of Disease Prevention (ODP) Announces the Pathways to Prevention Workshop: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication
Office of Disease Prevention
- Update for PAR-20-280 "Cooperative Research Agreements Related to the World Trade Center Health Program (U01)"
National Institute for Occupational Safety and Health
- Request for Information (RFI): Unhealthy Alcohol Use in Active Duty Military
National Institute on Alcohol Abuse and Alcoholism
- Request for Information (RFI): Research Opportunities to End Hunger, Food and Nutrition Insecurity.
Office of the Director, NIH
Office of Research on Women's Health
Notice of Changes to Funding Opportunities
- Notice of Early Expiration of NOT-AG-21-015 "Notice of Special Interest (NOSI): Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19)"
National Institute on Aging
- Notice of Correction to the Key Date Section in PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"
National Institute on Drug Abuse
- Notice of NHLBI Participation in PAR-21-154, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Required)"
National Heart, Lung, and Blood Institute
- Notice of NHLBI Participation in PAR-21-155, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute
- Notice of Change to Key Dates for RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
- Notice of Correction to Application and Submission Information for NOT-NS-21-068 "HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Advance the Study of Chronic Overlapping
National Institute of Neurological Disorders and Stroke
- Notice of Change to Application Types Allowed for RFA-NS-21-010 "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)"
National Institute of Neurological Disorders and Stroke
- Notice of Change to PAR-21-277 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
- Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
National Cancer Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN) Scientific Leadership Center (UM2 Clinical Trial Required), and Operations and Collaborations Center (UM1 Clinical Trial)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of Intent to Publish a Funding Opportunity Announcement for NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Evaluation of sex differences on HIV-associated comorbidities in the context of stimulant use
National Institute on Drug Abuse
Funding Opportunities
- Making Health Care Safer in Ambulatory Care Settings and Long-term Care Facilities (R18)
Agency for Healthcare Research and Quality
- Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
Office of the Director, NIH
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Center for Environmental Health
National Cancer Institute
National Center for Injury Prevention and Control
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Institute for Occupational Safety and Health
National Library of Medicine
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
John E. Fogarty International Center
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
John E. Fogarty International Center
National Cancer Institute
National Human Genome Research Institute
National Institute on Aging
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
- NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed)
- NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
- NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) National Cancer Institute
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
- Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Cancer Institute
- AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional)
National Institute on Drug Abuse
- Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional)
- Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional)
National Institute on Drug Abuse
- High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)
National Institute on Drug Abuse
- An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
- The Human BioMolecular Atlas Program (HuBMAP) Demonstration Project (U01 Clinical Trial Not Allowed)
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Lynn Hudachek at lynn-hudachek@uiowa.edu.